If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

My research focuses on how to find a novel and effective therapy for the treatment of inflammatory liver diseases.

Education/Academic qualification

Master, Gadjah Mada University

Bachelor, Bandung Institute of Technology

External positions

Lecturer and Researcher

1 Apr 2006 → …

Fingerprint Dive into the research topics where D.W. Kurniawan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Fatty Liver Medicine & Life Sciences
Nanoparticles Medicine & Life Sciences
Macrophages Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Alcoholic Hepatitis Medicine & Life Sciences
Inflammation Medicine & Life Sciences
polylactic acid-polyglycolic acid copolymer Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2018

  • 2 Citations
  • 1 h-Index
  • 2 Poster
  • 1 Article

PLGA nanoparticles-based delivery of SRC kinase signaling pathway inhibitor KX2-391 for the treatment of non-alcoholic steatohepatitis

Kurniawan, D. W., Dhawan, G., Oosterhuis, D., Storm, G., Olinga, P., Mishra, D. P., Prakash, J. & Bansal, R., 2018, p. 545.

Research output: Contribution to conferencePosterAcademic

2 Citations (Scopus)
15 Downloads (Pure)

Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis

Kurniawan, D. W., Jajoriya, A. K., Dhawan, G., Mishra, D., Argemi, J., Bataller, R., Storm, G., Mishra, D. P., Prakash, J. & Bansal, R., 28 Oct 2018, In : Journal of controlled release. 288, p. 227-238 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
Fatty Liver
Nanoparticles
Macrophages
Therapeutics
Fibrosis

Therapeutic inhibition of SYK kinase in macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis

Kurniawan, D. W., Jajoriya, A. K., Dhawan, G., Mishra, D. P., Storm, G., Mishra, D., Prakash, J. & Bansal, R., Oct 2018, p. 546.

Research output: Contribution to conferencePosterAcademic

Prizes

Posters
Fatty Liver
Nanoparticles
Phosphotransferases
N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide